Advertisement
Screener

MYRIAD GENETICS, INC. (MYGN) Property, Plant and Equipment, Gross

2.1 / 5 stars · 50/120 Roast Me

MYRIAD GENETICS, INC. Property, Plant and Equipment, Gross

MYRIAD GENETICS, INC. (MYGN) had Property, Plant and Equipment, Gross of $200.60 million as of 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization

us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-07-31

  • 2026-06-30: Property, Plant and Equipment, Gross $200.60M.
  • 2026-03-31: Property, Plant and Equipment, Gross $202.00M.
  • 2025-12-31: Property, Plant and Equipment, Gross $201.90M.
  • 2025-09-30: Property, Plant and Equipment, Gross $194.70M.
Period endProperty, Plant and Equipment, GrossProperty, Plant and Equipment, Gross as first filed
2026-06-30$200.60M
10-Q · filed 2026-07-31
2026-03-31$202.00M
10-Q · filed 2026-05-06
2025-12-31$201.90M
10-Q · filed 2026-07-31
2025-09-30$194.70M
10-Q · filed 2025-11-04
2025-06-30$192.40M
10-Q · filed 2025-08-06
2025-03-31$197.50M
10-Q · filed 2025-05-07
2024-12-31$227.00M
10-K · filed 2026-02-24
2024-09-30$232.70M
10-Q · filed 2024-11-08
2024-06-30$231.40M
10-Q · filed 2024-08-07
2024-03-31$229.30M
10-Q · filed 2024-05-08
2023-12-31$238.90M
10-K · filed 2025-02-28
2023-09-30$238.90M
10-Q · filed 2023-11-07
2023-06-30$226.90M
10-Q · filed 2023-08-04
2023-03-31$208.50M
10-Q · filed 2023-05-04
2022-12-31$192.60M
10-K · filed 2024-02-28
2022-09-30$176.00M
10-Q · filed 2022-11-02
2022-06-30$158.40M
10-Q · filed 2022-08-05
2022-03-31$149.10M
10-Q · filed 2022-05-06
2021-12-31$150.40M
10-K · filed 2023-03-01
2021-09-30$148.40M
10-Q · filed 2021-11-04
2021-06-30$146.10M
10-Q · filed 2021-08-04
2021-03-31$155.80M
10-Q · filed 2021-05-05
2020-12-31$153.60M
10-K · filed 2022-02-25
2020-09-30$146.70M
10-Q · filed 2020-11-09
2020-06-30$143.90M
10-KT · filed 2021-03-16
2020-03-31$142.30M
10-Q · filed 2020-05-06
2019-12-31$143.80M
10-Q · filed 2020-02-07
2019-09-30$167.00M
10-Q · filed 2019-11-06
2019-06-30$169.20M
10-KT · filed 2021-03-16
2019-03-31$167.80M
10-Q · filed 2019-05-08
2018-09-30$165.40M
10-Q · filed 2019-02-06
$164.50M
10-Q · filed 2018-11-07
2018-06-30$157.10M
10-K · filed 2019-08-13
2018-03-31$156.80M
10-Q · filed 2018-05-09
2017-12-31$154.80M
10-Q · filed 2018-02-07
2017-09-30$150.70M
10-Q · filed 2017-11-08
2017-06-30$148.40M
10-K · filed 2018-08-24
2017-03-31$146.30M
10-Q · filed 2017-05-03
2016-12-31$144.60M
10-Q · filed 2017-02-08
2016-09-30$143.30M
10-Q · filed 2016-11-02
2016-06-30$141.70M
10-K · filed 2017-08-09
2016-03-31$141.70M
10-Q · filed 2016-05-04
2015-12-31$139.20M
10-Q · filed 2016-02-03
2015-09-30$139.50M
10-Q · filed 2015-11-04
2015-06-30$138.10M
10-K · filed 2016-08-10
2015-03-31$136.63M
10-Q · filed 2015-05-06
2014-12-31$114.26M
10-Q · filed 2015-02-04
2014-09-30$108.59M
10-Q · filed 2014-11-05
2014-06-30$99.60M
10-K · filed 2015-08-12
$99.61M
10-K · filed 2014-08-13
2014-03-31$95.53M
10-Q · filed 2014-05-07
2013-12-31$91.96M
10-Q · filed 2014-02-05
2013-09-30$89.10M
10-Q · filed 2013-11-12
2013-06-30$84.20M
10-K · filed 2014-08-13
2013-03-31$81.07M
10-Q · filed 2013-05-08
2012-12-31$79.59M
10-Q · filed 2013-02-06
2012-09-30$75.21M
10-Q · filed 2012-11-09
2012-06-30$72.53M
10-K · filed 2013-08-14
2012-03-31$70.76M
10-Q · filed 2012-05-02
2011-12-31$69.20M
10-Q · filed 2012-02-01
2011-09-30$66.13M
10-Q · filed 2011-11-02
2011-06-30$64.11M
10-K · filed 2012-08-15
2011-03-31$68.28M
10-Q · filed 2011-05-04
2010-06-30$65.27M
10-K · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92